|
Delayed
OTC Markets
11:50:45 07/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.7500 USD | +2.88% |
|
0.00% | -71.15% |
| 02:04pm | 15 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| 15/10 | 14 stocks have so far today hit new 52-week lows on the Stockholm Stock Exchange | FW |
| Market Cap | 21Cr 2.15Cr 1.92Cr 1.77Cr 1.61Cr 3.03Cr 203.74Cr 3.08Cr 8.37Cr 106.49Cr 8.06Cr 7.89Cr 340.42Cr | P/E 2024 |
-2.97x | P/E 2025 | 1.63x |
|---|---|---|---|---|---|
| Enterprise Value | -21Cr -2.1Cr -1.87Cr -1.73Cr -1.58Cr -2.96Cr -199.17Cr -3.01Cr -8.18Cr -104.1Cr -7.88Cr -7.72Cr -332.77Cr | EV / Sales 2024 |
1.62x | EV / Sales 2025 | 23.8x |
| Free-Float |
78.37% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Orexo AB
| 1 day | +2.88% | ||
| Current month | -31.82% | ||
| 1 month | -46.04% | ||
| 3 months | -58.33% | ||
| 6 months | -71.70% | ||
| Current year | -71.15% |
| 1 month | 0.73 |  | 1.26 |
| Current year | 0.73 | | 2.65 |
| 1 year | 0.73 | | 3 |
| 3 years | 0.73 | | 4.05 |
| 5 years | 0.73 | | 4.05 |
| 10 years | 0.73 | | 9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nikolaj Sørensen
CEO | Chief Executive Officer | 54 | 05/02/2013 |
Fredrik Järrsten
DFI | Director of Finance/CFO | 59 | 01/09/2022 |
Jonas Savmarker
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 64 | 01/01/2002 | |
George Wilkinson
BRD | Director/Board Member | 70 | 11/04/2019 |
Christine Rankin
BRD | Director/Board Member | 62 | 01/04/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.88% | 0.00% | - | - | 2.15Cr | |
| +3.39% | +4.88% | +54.50% | +109.94% | 1,10600Cr | |
| +2.09% | -3.77% | +31.35% | +66.62% | 61TCr | |
| +1.58% | +0.55% | +23.13% | +94.26% | 50TCr | |
| +1.85% | +7.20% | +37.21% | +61.38% | 37TCr | |
| +3.05% | -1.25% | +69.39% | +43.02% | 35TCr | |
| +1.27% | +5.13% | +20.43% | +47.90% | 29TCr | |
| +1.35% | +4.89% | -0.68% | +19.64% | 26TCr | |
| +1.76% | +1.76% | +42.21% | +51.44% | 23TCr | |
| +2.14% | +1.75% | +24.64% | +95.14% | 19TCr | |
| Average | +2.05% | +2.13% | +33.58% | +65.48% | 43.33TCr | |
| Weighted average by Cap. | +2.27% | +2.30% | +38.28% | +75.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 59Cr 5.96Cr 5.31Cr 4.92Cr 4.47Cr 8.39Cr 564.79Cr 8.53Cr 23Cr 295.19Cr 22Cr 22Cr 943.65Cr | 2.6Cr 26.25L 23.4L 21.68L 19.71L 36.98L 25Cr 37.59L 1.02Cr 13Cr 98.49L 96.43L 42Cr |
| Net income | -20Cr -2.05Cr -1.83Cr -1.69Cr -1.54Cr -2.89Cr -194.33Cr -2.94Cr -7.98Cr -101.57Cr -7.69Cr -7.53Cr -324.68Cr | 64Cr 6.45Cr 5.75Cr 5.33Cr 4.85Cr 9.09Cr 611.98Cr 9.24Cr 25Cr 319.86Cr 24Cr 24Cr 1.02TCr |
| Net Debt | 35Cr 3.56Cr 3.17Cr 2.94Cr 2.67Cr 5.02Cr 337.63Cr 5.1Cr 14Cr 176.46Cr 13Cr 13Cr 564.11Cr | -42Cr -4.25Cr -3.79Cr -3.51Cr -3.19Cr -5.99Cr -402.91Cr -6.09Cr -17Cr -210.59Cr -16Cr -16Cr -673.19Cr |
Employees
61
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | $0.000000 | - | 8 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ORX Stock
- ORXOY Stock
Select your edition
All financial news and data tailored to specific country editions
